According to the research report, the global market for Human Organs-on-Chips should grow from US$ 88 million in 2022 to US$ 621.2 million by 2029, with a CAGR of 31.2% for the period of 2023-2029.
Global key players of Human Organs-on-Chips include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, etc. The top five players hold a share over 55%. North America is the largest market, has a share about 42%, followed by Europe, and Asia-Pacific, with share 35% and 18%, separately. In terms of product type, Liver-on-a-chip is the largest segment, occupied for a share of 26%, and in terms of application, Pharmaceutical & Biotechnology Companies has a share about 70%.
This report studies and analyses global Human Organs-on-Chips status and future trends, to help determine the Human Organs-on-Chips market size of the total market opportunity by Type, by End User, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Human Organs-on-Chips, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Report Highlights
(1) Global Human Organs-on-Chips market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Human Organs-on-Chips by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Human Organs-on-Chips by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Human Organs-on-Chips key consuming regions, consumption value and demand structure
(5) Human Organs-on-Chips industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech
Market segment by Type, covers
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Market segment by End User, can be divided into
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Key Findings from The Report:
Chapter 1: to describe Human Organs-on-Chips product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Human Organs-on-Chips market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Human Organs-on-Chips market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Human Organs-on-Chips industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by End User, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Human Organs-on-Chips Definition
1.2 Global Human Organs-on-Chips Market Size and Forecast
1.3 China Human Organs-on-Chips Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Human Organs-on-Chips Market Size: China VS Global Growth Rate, 2018-2029
1.6 Human Organs-on-Chips Market Dynamics
1.6.1 Human Organs-on-Chips Market Drivers
1.6.2 Human Organs-on-Chips Market Restraints
1.6.3 Human Organs-on-Chips Industry Trends
1.6.4 Human Organs-on-Chips Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Human Organs-on-Chips, Global Market Share by Company, 2018-2023
2.2 Global Human Organs-on-Chips Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Human Organs-on-Chips Concentration Ratio
2.4 Global Human Organs-on-Chips Mergers & Acquisitions, Expansion Plans
2.5 Global Human Organs-on-Chips Major Companies Product Type
2.6 Head Office and Human Organs-on-Chips Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Human Organs-on-Chips, China Market Share by Company, 2018-2023
3.2 China Human Organs-on-Chips Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Human Organs-on-Chips Industry Chain
4.2 Human Organs-on-Chips Upstream Analysis
4.2.1 Human Organs-on-Chips Core Raw Materials
4.2.2 Main Manufacturers of Human Organs-on-Chips Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Human Organs-on-Chips Production Mode
4.6 Human Organs-on-Chips Procurement Model
4.7 Human Organs-on-Chips Industry Sales Model and Sales Channels
4.7.1 Human Organs-on-Chips Sales Model
4.7.2 Human Organs-on-Chips Typical Distributors
5 Sights by Type
5.1 Human Organs-on-Chips Classification
5.1.1 Brain-on-a-chip
5.1.2 Liver-on-a-chip
5.1.3 Kidney-on-a-chip
5.1.4 Lung-on-a-chip
5.1.5 Heart-on-a-chip
5.1.6 Intestine-on-a-chip
5.1.7 Vessel-on-a-chip
5.1.8 Other Organs
5.2 By Type, Global Human Organs-on-Chips Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Human Organs-on-Chips Consumption Value, 2018-2029
6 Sights by End User
6.1 Human Organs-on-Chips Segment by End User
6.1.1 Pharmaceutical & Biotechnology Companies
6.1.2 Academic & Research Institutes
6.1.3 Cosmetics Industry
6.1.4 Others
6.2 By End User, Global Human Organs-on-Chips Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By End User, Global Human Organs-on-Chips Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Human Organs-on-Chips Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Human Organs-on-Chips Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Human Organs-on-Chips & Forecasts, 2018-2029
7.3.2 By Country, North America Human Organs-on-Chips Market Size Market Share
7.4 Europe
7.4.1 Europe Human Organs-on-Chips Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Human Organs-on-Chips Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Human Organs-on-Chips Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Human Organs-on-Chips Market Size Market Share
7.6 South America
7.6.1 South America Human Organs-on-Chips Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Human Organs-on-Chips Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Human Organs-on-Chips Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Human Organs-on-Chips Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Human Organs-on-Chips Market Size, 2018-2029
8.3.2 By Type, U.S. Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.3.3 By End User, U.S. Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Human Organs-on-Chips Market Size, 2018-2029
8.4.2 By Type, Europe Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.4.3 By End User, Europe Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Human Organs-on-Chips Market Size, 2018-2029
8.5.2 By Type, China Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.5.3 By End User, China Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Human Organs-on-Chips Market Size, 2018-2029
8.6.2 By Type, Japan Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.6.3 By End User, Japan Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Human Organs-on-Chips Market Size, 2018-2029
8.7.2 By Type, South Korea Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.7.3 By End User, South Korea Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Human Organs-on-Chips Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.8.3 By End User, Southeast Asia Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Human Organs-on-Chips Market Size, 2018-2029
8.9.2 By Type, India Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.9.3 By End User, India Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Human Organs-on-Chips Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
8.10.3 By End User, Middle East & Africa Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Emulate
9.1.1 Emulate Company Information, Head Office, Market Area and Industry Position
9.1.2 Emulate Company Profile and Main Business
9.1.3 Emulate Human Organs-on-Chips Models, Specifications and Application
9.1.4 Emulate Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.1.5 Emulate Recent Developments
9.2 Mimetas
9.2.1 Mimetas Company Information, Head Office, Market Area and Industry Position
9.2.2 Mimetas Company Profile and Main Business
9.2.3 Mimetas Human Organs-on-Chips Models, Specifications and Application
9.2.4 Mimetas Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.2.5 Mimetas Recent Developments
9.3 TissUse
9.3.1 TissUse Company Information, Head Office, Market Area and Industry Position
9.3.2 TissUse Company Profile and Main Business
9.3.3 TissUse Human Organs-on-Chips Models, Specifications and Application
9.3.4 TissUse Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.3.5 TissUse Recent Developments
9.4 Valo Health
9.4.1 Valo Health Company Information, Head Office, Market Area and Industry Position
9.4.2 Valo Health Company Profile and Main Business
9.4.3 Valo Health Human Organs-on-Chips Models, Specifications and Application
9.4.4 Valo Health Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.4.5 Valo Health Recent Developments
9.5 CN Bio Innovations
9.5.1 CN Bio Innovations Company Information, Head Office, Market Area and Industry Position
9.5.2 CN Bio Innovations Company Profile and Main Business
9.5.3 CN Bio Innovations Human Organs-on-Chips Models, Specifications and Application
9.5.4 CN Bio Innovations Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.5.5 CN Bio Innovations Recent Developments
9.6 Hesperos
9.6.1 Hesperos Company Information, Head Office, Market Area and Industry Position
9.6.2 Hesperos Company Profile and Main Business
9.6.3 Hesperos Human Organs-on-Chips Models, Specifications and Application
9.6.4 Hesperos Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.6.5 Hesperos Recent Developments
9.7 Draper Laboratory
9.7.1 Draper Laboratory Company Information, Head Office, Market Area and Industry Position
9.7.2 Draper Laboratory Company Profile and Main Business
9.7.3 Draper Laboratory Human Organs-on-Chips Models, Specifications and Application
9.7.4 Draper Laboratory Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.7.5 Draper Laboratory Recent Developments
9.8 Nortis
9.8.1 Nortis Company Information, Head Office, Market Area and Industry Position
9.8.2 Nortis Company Profile and Main Business
9.8.3 Nortis Human Organs-on-Chips Models, Specifications and Application
9.8.4 Nortis Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.8.5 Nortis Recent Developments
9.9 Micronit Microtechnologies B.V.
9.9.1 Micronit Microtechnologies B.V. Company Information, Head Office, Market Area and Industry Position
9.9.2 Micronit Microtechnologies B.V. Company Profile and Main Business
9.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Models, Specifications and Application
9.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.9.5 Micronit Microtechnologies B.V. Recent Developments
9.10 Kirkstall
9.10.1 Kirkstall Company Information, Head Office, Market Area and Industry Position
9.10.2 Kirkstall Company Profile and Main Business
9.10.3 Kirkstall Human Organs-on-Chips Models, Specifications and Application
9.10.4 Kirkstall Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.10.5 Kirkstall Recent Developments
9.11 Cherry Biotech SAS
9.11.1 Cherry Biotech SAS Company Information, Head Office, Market Area and Industry Position
9.11.2 Cherry Biotech SAS Company Profile and Main Business
9.11.3 Cherry Biotech SAS Human Organs-on-Chips Models, Specifications and Application
9.11.4 Cherry Biotech SAS Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.11.5 Cherry Biotech SAS Recent Developments
9.12 Else Kooi Laboratory
9.12.1 Else Kooi Laboratory Company Information, Head Office, Market Area and Industry Position
9.12.2 Else Kooi Laboratory Company Profile and Main Business
9.12.3 Else Kooi Laboratory Human Organs-on-Chips Models, Specifications and Application
9.12.4 Else Kooi Laboratory Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.12.5 Else Kooi Laboratory Recent Developments
9.13 Altis Biosystems
9.13.1 Altis Biosystems Company Information, Head Office, Market Area and Industry Position
9.13.2 Altis Biosystems Company Profile and Main Business
9.13.3 Altis Biosystems Human Organs-on-Chips Models, Specifications and Application
9.13.4 Altis Biosystems Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.13.5 Altis Biosystems Recent Developments
9.14 Bi/ond
9.14.1 Bi/ond Company Information, Head Office, Market Area and Industry Position
9.14.2 Bi/ond Company Profile and Main Business
9.14.3 Bi/ond Human Organs-on-Chips Models, Specifications and Application
9.14.4 Bi/ond Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.14.5 Bi/ond Recent Developments
9.15 Netri
9.15.1 Netri Company Information, Head Office, Market Area and Industry Position
9.15.2 Netri Company Profile and Main Business
9.15.3 Netri Human Organs-on-Chips Models, Specifications and Application
9.15.4 Netri Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.15.5 Netri Recent Developments
9.16 Xona Microfluidics
9.16.1 Xona Microfluidics Company Information, Head Office, Market Area and Industry Position
9.16.2 Xona Microfluidics Company Profile and Main Business
9.16.3 Xona Microfluidics Human Organs-on-Chips Models, Specifications and Application
9.16.4 Xona Microfluidics Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.16.5 Xona Microfluidics Recent Developments
9.17 SynVivo
9.17.1 SynVivo Company Information, Head Office, Market Area and Industry Position
9.17.2 SynVivo Company Profile and Main Business
9.17.3 SynVivo Human Organs-on-Chips Models, Specifications and Application
9.17.4 SynVivo Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.17.5 SynVivo Recent Developments
9.18 Beijing Daxiang Biotech
9.18.1 Beijing Daxiang Biotech Company Information, Head Office, Market Area and Industry Position
9.18.2 Beijing Daxiang Biotech Company Profile and Main Business
9.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Models, Specifications and Application
9.18.4 Beijing Daxiang Biotech Human Organs-on-Chips Revenue and Gross Margin, 2018-2023
9.18.5 Beijing Daxiang Biotech Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Human Organs-on-Chips Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Human Organs-on-Chips Market Restraints
Table 3. Human Organs-on-Chips Market Trends
Table 4. Human Organs-on-Chips Industry Policy
Table 5. Global Human Organs-on-Chips Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Human Organs-on-Chips Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Human Organs-on-Chips Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Human Organs-on-Chips Mergers & Acquisitions, Expansion Plans
Table 9. Global Human Organs-on-Chips Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Human Organs-on-Chips Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Human Organs-on-Chips Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Human Organs-on-Chips Upstream (Raw Materials)
Table 14. Global Human Organs-on-Chips Typical Customers
Table 15. Human Organs-on-Chips Typical Distributors
Table 16. By Type, Global Human Organs-on-Chips Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By End User, Global Human Organs-on-Chips Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Human Organs-on-Chips Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Human Organs-on-Chips Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Human Organs-on-Chips Consumption Value Market Share, 2018-2029
Table 23. Emulate Company Information, Head Office, Market Area and Industry Position
Table 24. Emulate Company Profile and Main Business
Table 25. Emulate Human Organs-on-Chips Models, Specifications, and Application
Table 26. Emulate Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Emulate Recent Developments
Table 28. Mimetas Company Information, Head Office, Market Area and Industry Position
Table 29. Mimetas Company Profile and Main Business
Table 30. Mimetas Human Organs-on-Chips Models, Specifications, and Application
Table 31. Mimetas Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Mimetas Recent Developments
Table 33. TissUse Company Information, Head Office, Market Area and Industry Position
Table 34. TissUse Company Profile and Main Business
Table 35. TissUse Human Organs-on-Chips Models, Specifications, and Application
Table 36. TissUse Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. TissUse Recent Developments
Table 38. Valo Health Company Information, Head Office, Market Area and Industry Position
Table 39. Valo Health Company Profile and Main Business
Table 40. Valo Health Human Organs-on-Chips Models, Specifications, and Application
Table 41. Valo Health Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Valo Health Recent Developments
Table 43. CN Bio Innovations Company Information, Head Office, Market Area and Industry Position
Table 44. CN Bio Innovations Company Profile and Main Business
Table 45. CN Bio Innovations Human Organs-on-Chips Models, Specifications, and Application
Table 46. CN Bio Innovations Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. CN Bio Innovations Recent Developments
Table 48. Hesperos Company Information, Head Office, Market Area and Industry Position
Table 49. Hesperos Company Profile and Main Business
Table 50. Hesperos Human Organs-on-Chips Models, Specifications, and Application
Table 51. Hesperos Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Hesperos Recent Developments
Table 53. Draper Laboratory Company Information, Head Office, Market Area and Industry Position
Table 54. Draper Laboratory Company Profile and Main Business
Table 55. Draper Laboratory Human Organs-on-Chips Models, Specifications, and Application
Table 56. Draper Laboratory Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Draper Laboratory Recent Developments
Table 58. Nortis Company Information, Head Office, Market Area and Industry Position
Table 59. Nortis Company Profile and Main Business
Table 60. Nortis Human Organs-on-Chips Models, Specifications, and Application
Table 61. Nortis Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Nortis Recent Developments
Table 63. Micronit Microtechnologies B.V. Company Information, Head Office, Market Area and Industry Position
Table 64. Micronit Microtechnologies B.V. Company Profile and Main Business
Table 65. Micronit Microtechnologies B.V. Human Organs-on-Chips Models, Specifications, and Application
Table 66. Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Micronit Microtechnologies B.V. Recent Developments
Table 68. Kirkstall Company Information, Head Office, Market Area and Industry Position
Table 69. Kirkstall Company Profile and Main Business
Table 70. Kirkstall Human Organs-on-Chips Models, Specifications, and Application
Table 71. Kirkstall Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Kirkstall Recent Developments
Table 73. Cherry Biotech SAS Company Information, Head Office, Market Area and Industry Position
Table 74. Cherry Biotech SAS Company Profile and Main Business
Table 75. Cherry Biotech SAS Human Organs-on-Chips Models, Specifications, and Application
Table 76. Cherry Biotech SAS Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Cherry Biotech SAS Recent Developments
Table 78. Else Kooi Laboratory Company Information, Head Office, Market Area and Industry Position
Table 79. Else Kooi Laboratory Company Profile and Main Business
Table 80. Else Kooi Laboratory Human Organs-on-Chips Models, Specifications, and Application
Table 81. Else Kooi Laboratory Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. Else Kooi Laboratory Recent Developments
Table 83. Altis Biosystems Company Information, Head Office, Market Area and Industry Position
Table 84. Altis Biosystems Company Profile and Main Business
Table 85. Altis Biosystems Human Organs-on-Chips Models, Specifications, and Application
Table 86. Altis Biosystems Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 87. Altis Biosystems Recent Developments
Table 88. Bi/ond Company Information, Head Office, Market Area and Industry Position
Table 89. Bi/ond Company Profile and Main Business
Table 90. Bi/ond Human Organs-on-Chips Models, Specifications, and Application
Table 91. Bi/ond Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 92. Bi/ond Recent Developments
Table 93. Netri Company Information, Head Office, Market Area and Industry Position
Table 94. Netri Company Profile and Main Business
Table 95. Netri Human Organs-on-Chips Models, Specifications, and Application
Table 96. Netri Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 97. Netri Recent Developments
Table 98. Xona Microfluidics Company Information, Head Office, Market Area and Industry Position
Table 99. Xona Microfluidics Company Profile and Main Business
Table 100. Xona Microfluidics Human Organs-on-Chips Models, Specifications, and Application
Table 101. Xona Microfluidics Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 102. Xona Microfluidics Recent Developments
Table 103. SynVivo Company Information, Head Office, Market Area and Industry Position
Table 104. SynVivo Company Profile and Main Business
Table 105. SynVivo Human Organs-on-Chips Models, Specifications, and Application
Table 106. SynVivo Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 107. SynVivo Recent Developments
Table 108. Beijing Daxiang Biotech Company Information, Head Office, Market Area and Industry Position
Table 109. Beijing Daxiang Biotech Company Profile and Main Business
Table 110. Beijing Daxiang Biotech Human Organs-on-Chips Models, Specifications, and Application
Table 111. Beijing Daxiang Biotech Human Organs-on-Chips Revenue and Gross Margin, US$ Million, 2018-2023
Table 112. Beijing Daxiang Biotech Recent Developments
List of Figures
Figure 1. Human Organs-on-Chips Picture
Figure 2. Global Human Organs-on-Chips Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Human Organs-on-Chips Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Human Organs-on-Chips Market Share of Global, 2018-2029
Figure 5. Global Human Organs-on-Chips Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Human Organs-on-Chips Key Participants, Market Share, 2022
Figure 7. Human Organs-on-Chips Industry Chain
Figure 8. Human Organs-on-Chips Procurement Model
Figure 9. Human Organs-on-Chips Sales Model
Figure 10. Human Organs-on-Chips Sales Channels, Direct Sales, and Distribution
Figure 11. Brain-on-a-chip
Figure 12. Liver-on-a-chip
Figure 13. Kidney-on-a-chip
Figure 14. Lung-on-a-chip
Figure 15. Heart-on-a-chip
Figure 16. Intestine-on-a-chip
Figure 17. Vessel-on-a-chip
Figure 18. Other Organs
Figure 19. By Type, Global Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Figure 20. By Type, Global Human Organs-on-Chips Consumption Value Market Share, 2018-2029
Figure 21. Pharmaceutical & Biotechnology Companies
Figure 22. Academic & Research Institutes
Figure 23. Cosmetics Industry
Figure 24. Others
Figure 25. By End User, Global Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Figure 26. By End User, Global Human Organs-on-Chips Consumption Value Market Share, 2018-2029
Figure 27. By Region, Global Human Organs-on-Chips Consumption Value Market Share, 2018-2029
Figure 28. North America Human Organs-on-Chips Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, North America Human Organs-on-Chips Consumption Value Market Share, 2022
Figure 30. Europe Human Organs-on-Chips Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. By Country, Europe Human Organs-on-Chips Consumption Value Market Share, 2022
Figure 32. Asia Pacific Human Organs-on-Chips Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 33. By Country/Region, Asia Pacific Human Organs-on-Chips Consumption Value Market Share, 2022
Figure 34. South America Human Organs-on-Chips Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 35. By Country, South America Human Organs-on-Chips Consumption Value Market Share, 2022
Figure 36. Middle East & Africa Human Organs-on-Chips Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. U.S. Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Figure 38. By Type, U.S. Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 39. By End User, U.S. Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 40. Europe Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Figure 41. By Type, Europe Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 42. By End User, Europe Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 43. China Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Figure 44. By Type, China Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 45. By End User, China Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 46. Japan Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Figure 47. By Type, Japan Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 48. By End User, Japan Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 49. South Korea Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Figure 50. By Type, South Korea Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 51. By End User, South Korea Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 52. Southeast Asia Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Figure 53. By Type, Southeast Asia Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 54. By End User, Southeast Asia Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 55. India Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Figure 56. By Type, India Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 57. By End User, India Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 58. Middle East & Africa Human Organs-on-Chips Consumption Value, 2018-2029, US$ Million
Figure 59. By Type, Middle East & Africa Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 60. By End User, Middle East & Africa Human Organs-on-Chips Consumption Value Market Share, 2022 VS 2029
Figure 61. Research Methodology
Figure 62. Breakdown of Primary Interviews
Figure 63. Bottom-up and Top-down Approaches
Figure 64. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|